Fluorescence Targeted Pelvic Lymph Node Mapping
NCT03204994
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
1
Enrollment
OTHER
Sponsor class
Stopped
Not able to recruit
Conditions
Cancer of Rectum
Lymph Node Disease
Interventions
DRUG:
Indocyanine Green
Sponsor
Oxford University Hospitals NHS Trust